SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy sets up second manufacturing unit in S. Africa

02 Sep 2010 Evaluate

Ranbaxy Laboratories Ltd  has set up a new manufacturing facility in South Africa with an investment of $30 million.The new facility will manufacture analgesics, cold, cough and flu preparations, anti-histamines, anti-hypertensive, CNS drugs, vitamins and minerals as well as a comprehensive range of over-the-counter medication. The plant is capable of producing approximately 1.75 billion units and packaging of 2 billion units, annually.

The products manufactured will comprise tablets and hard gelatin capsules that will be supplied to current registered regions. This is the second manufacturing unit in South Africa and the third in the African continent after Nigeria.

crackcrack
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×